Windtree Therapeutics, Inc. (WINT) Stock Forecast
WINT analyst forecast
as of October 21, 2026- Analyst consensus
- Hold 3.00 / 5 from 1 analysts
- Price target
- $4.00 average of analyst targets
- Upside to target
- +399,900.0% from the latest close
- Next earnings
- —
- 52-week range
- $0.00 – $0.00
WINT analyst ratings
1 analystsNumber of analysts at each rating.
WINT price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
WINT earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next fiscal year (2026) | $0.00 | $0.00 | $0.00 | −$486.50 | — | — |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
WINT revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next fiscal year (2026) | $0 | $0 | $0 | — | — |
WINT EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
WINT EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next fiscal year (2026) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
WINT earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; WINT beat in 4 of 12.
What analysts expect from WINT
1 analysts cover Windtree Therapeutics; their consensus rating is hold (3.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $4.00, 399,900.0% above the latest close of $0.00. For 2026 the average estimate is $0.00 per share. Windtree Therapeutics beat the EPS estimate in 4 of the last 12 quarters.
Related: WINT income statement, WINT key metrics, WINT chart. See the WINT stock overview for the latest quote and news.
WINT forecast FAQ
What is Windtree Therapeutics's price target?
The average analyst price target for Windtree Therapeutics is $4.00, 399,900.0% above the latest close of $0.00.
Is Windtree Therapeutics a buy, hold or sell?
Of 1 analysts covering Windtree Therapeutics, 0 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
Does Windtree Therapeutics usually beat earnings estimates?
Windtree Therapeutics reported EPS at or above the analyst estimate in 4 of the last 12 quarters.